Subhash Kapre
Subhash Kapre is Executive Chairman at Inventprise and Chairman at InventVacc Biologicals Inc. He was Executive Director at Serum Institute of India Limited.
Recent coverage
Front-page news, podcasts and videos about Subhash
Bill & Melinda Gates Foundation Pledges up to $90M to Fund Inventprise’s 25-Strain Pediatric Pneumococcal Vaccine Trials
Seattle-area biotech Inventprise will use up to $90 million from the Bill & Melinda Gates Foundation to advance a 25-strain pediatric pneumococcal vaccine into phase 1 and 2 human trials, contingent on meeting development and manufacturing milestones.
Organizations
-
Inventprise Executive Chairman 2021–present, CEO 2013–2021 · current
-
InventVacc Biologicals Inc Chairman 2016–present · current
-
Serum Institute of India Limited Executive Director 1969–2011 · past
Education
-
Savitribai Phule Pune University Doctorate in Philosophy, Biochemistry/Microbiology · 1969–1975
Online
Questions about Subhash Kapre
Who is Subhash Kapre?
Subhash Kapre has been executive chairman at Inventprise since 2021 and chairman at InventVacc Biologicals Inc since 2016. Subhash was CEO at Inventprise from 2013 to 2021 and executive director at Serum Institute of India Limited from 1969 to 2011.
What has Subhash Kapre been in the news for?
GeekWire reported in November 2021 on Inventprise’s pediatric pneumococcal vaccine trials.
Which organizations is Subhash Kapre associated with?
Subhash Kapre is associated with Inventprise as executive chairman from 2021 to present and previously as CEO from 2013 to 2021. Subhash is also chairman at InventVacc Biologicals Inc from 2016 to present and was executive director at Serum Institute of India Limited from 1969 to 2011.
Where did Subhash Kapre study?
Subhash Kapre studied at Savitribai Phule Pune University from 1969 to 1975, earning a Doctorate in Philosophy in Biochemistry/Microbiology.
Where is Subhash Kapre based?
Subhash Kapre is based in Redmond, Washington, United States.
Where can I find Subhash Kapre online?
Subhash Kapre is on LinkedIn.